Since May 15, 2026, CBD remains legal in France, but with a clear dividing line: any product intended for ingestion is prohibited without Novel Food from the European Commission. In practical terms, gummies, oils for swallowing, infusions, and CBD food supplements have disappeared from legal shelves. However, e-liquids, cosmetics, topicals, and flowers from certified varieties remain marketable, under strict conditions.
What you need to remember immediately:
- Prohibited : any food containing CBD without Novel Food authorization (ingestible oils, gummies, infusions, food supplements).
- Allowed under certain conditions : e-liquids, cosmetics, topicals, hemp flowers and resins from certified EU varieties, with a THC level ≤ 0.3%.
- Immediate verification : require a Certificate of Analysis (COA) per batch, signed by an accredited independent laboratory, before any purchase.
The authorities that enforce these rules are the ANSM (French National Agency for Medicines and Health Products Safety), the DGAL (Directorate General for Food), the Ministry of Health, and the RASFF network for cross-border food alerts. Lord Of CBD, a player in the French cannabidiol market, publishes its Certificates of Analysis (COA) by batch and only offers products that comply with this framework.
Key points
| Point | Details |
|---|---|
| CBD food ban | Any food containing CBD without Novel Food authorization is illegal as of May 15, 2026. |
| Legal THC threshold | The THC content must be ≤ 0.3% by dry mass for any CBD product marketed in France. |
| COA per batch required | Require a certificate of analysis signed by an ISO 17025 accredited laboratory, corresponding to the exact batch number. |
| Medical precautions | Consult a doctor before use if you are taking chronic medication; do not drive after consumption. |
| Lord Of CBD | Offers compliant flowers, resins, e-liquids and cosmetics, with COA per batch available on request. |
Table of Contents
- What changed on May 15, 2026 with the Novel Food Regulation?
- Which CBD products are prohibited, and which remain possible?
- THC threshold and analytical evidence: how compliance is verified
- How can I check a CBD product before buying it?
- What are the risks for traders who do not comply?
- Is it safe to smoke CBD in public, carry it on your person, or travel with it?
- Side effects, drug interactions and precautions
- You have purchased a CBD food product: what should you do?
- The chronology of legal decisions that have shaped the current framework
- What to do today if you are a consumer or a shop?
- The CBD market in France deserves better than vague regulations
- Lord Of CBD: compliant products, batch analyses available
- Sources
What changed on May 15, 2026 with the Novel Food Regulation?
The European Novel Food Regulation (EU Regulation 2015/2283) covers any food or food ingredient that was not consumed in significant quantities in the EU before May 1997. CBD-rich hemp extracts were classified as "novel foods" from 2019, which requires any operator wishing to market them in food form to obtain prior authorization from the European Commission.
TheEFSA published provisional information on a safe level of CBD exposure and requested further data from applicants. This incomplete scientific assessment led the Commission to keep the applications pending, without granting authorization. As a result, no CBD food product currently has a valid Novel Food authorization in Europe.
In France, the concrete implementation of this ban has been set for May 15, 2026. The DGAL (Directorate General for Food) coordinates food inspections in the field, the ANSM (National Agency for Medicines and Health Products Safety) monitors products at the intersection of medicine and supplement classifications, and the Ministry of Health has confirmed its alignment with the European position. Shops that have not removed their food stocks by this date are subject to administrative seizures.
Which CBD products are prohibited, and which remain possible?
The distinction is simple on paper, less obvious on the shelves. The central criterion: is the product intended to be ingested?
Products now prohibited from sale (without Novel Food authorization):
- CBD oils designed for oral administration (sublingual or swallowed)
- CBD gummies, candies and sweets
- Infusions and herbal teas containing CBD extracts
- CBD-based food supplements in capsules or tablets
- CBD-enriched drinks
- Any functional food incorporating cannabidiol as an active ingredient
Products that remain marketable under certain conditions:
- E-liquids for vaporization (not for ingestion, THC ≤ 0.3%)
- Cosmetics and topical treatments containing CBD (creams, balms, massage oils)
- Hemp flowers and resins from EU-certified varieties, with THC ≤ 0.3%
- Flower-based smoking or vaporizing products, subject to varietal conformity
The gray areas deserve attention. Full-spectrum resins and extracts are particularly closely monitored: their status depends on their declared intended use (topical or inhalation use vs. ingestion) and their THC content. A resin marketed as a smoking product remains within the legal framework; the same resin presented as a food supplement falls under the Novel Food prohibition. Labeling and usage claims make all the difference during an inspection.
THC threshold and analytical evidence: how compliance is verified
This threshold applies to the plant and to the non-food finished products that are still authorized.
Proof of conformity relies on the batch certificate of analysis (COA) . Here are the elements that a valid COA must contain:
| COA section | What you need to check |
|---|---|
| Laboratory identity | ISO 17025 accreditation or equivalent, independent of the seller |
| Analytical method | GC-FID or LC-MS/MS for cannabinoids (method explicitly cited) |
| THC levels | Numerical value ≤ 0.3%, with LOD and LOQ indicated |
| declared CBD level | Corresponds to the concentration stated on the label |
| Batch number | Must correspond exactly to the batch of the product purchased |
| Varietal origin | Variety listed in the European seed catalogue |
| Contaminants | Heavy metals, solvent residues, pesticides (limit values respected) |
Pro tip: Always ask for the Certificate of Authenticity (COA) corresponding to the batch number printed on your packaging. A generic COA or one that is more than 12 months old does not guarantee the conformity of the product you have in your possession.
During inspections, the DGAL requires a Certificate of Analysis (COA) signed by an accredited laboratory, a statement of the analytical method, the limits of detection and quantification (LOD/LOQ), and a certificate of varietal origin. Without these elements, the product is considered at risk and may be seized.
How can I check a CBD product before buying it?
Whether you buy in-store or online, a five-step verification protects you.
-
Read the entire label. The product must state: the CBD concentration, the batch number, the manufacturing date, the manufacturer's name and address, and the intended use (topical, inhalation, etc.). Any medical or therapeutic claim is an immediate red flag.
-
Request the Certificate of Analysis (COA) for your batch. A reputable seller will provide it without hesitation, in PDF format, with the batch number clearly visible. Verify that the laboratory is ISO 17025 accredited and independent of the brand.
-
Confirm the varietal origin. The hemp variety must be listed in the European seed catalogue. If the seller cannot provide this information, walk away.
-
Check the extraction method. Supercritical CO₂ extraction is the gold standard: it doesn't use residual chemical solvents and preserves the cannabinoid profile. Solvent extraction (ethanol, hexane) is acceptable if the Certificate of Analysis (COA) confirms the absence of residues. Be wary of products where the extraction method isn't specified. For more information on premium CBD quality criteria, the points to check are detailed.
-
Keep your proof of purchase. Save the invoice, the Certificate of Authenticity (COA), and a photo of the packaging with the batch number. In case of any problem, these documents are essential for any recourse.
Warning signs that should make you refrain from buying: labeling in a foreign language only, absence of a batch number, claims such as "cures", "treats" or "relieves" a specific condition, unknown or unaccredited testing laboratory, abnormally low price without explanation.
What are the risks for traders who do not comply?
The consequences of non-compliance after May 15, 2026 are concrete and graduated.
- Administrative seizures : the DGAL and the services of the DGCCRF can seize stocks of CBD food products without Novel Food authorization, without compensation.
- Withdrawals and recalls : a non-compliant batch may be subject to a withdrawal from the market or a consumer recall published on Rappel, with notification to the RASFF network if the product has circulated in several Member States.
- Formal notices and fines : marketing an unauthorized food product constitutes an infringement of health regulations, punishable by administrative fines and, in serious cases, criminal prosecution.
- Damage to reputation : a public recall on rappel.conso.gouv.fr is indexed and permanently visible. For a specialized store, this represents a major commercial risk.
Reports on rappel.conso.gouv.fr are managed by the DGCCRF.
Is it safe to smoke CBD in public, carry it on your person, or travel with it?
There is no legal limit on the quantity for personal use, but a large quantity may attract the attention of law enforcement, who do not always have a field test to distinguish CBD from illicit cannabis.
Smoking CBD in public is technically permitted in areas where smoking is allowed, but the risk of being stopped is real. Hemp smells identical to recreational cannabis, and police officers cannot distinguish between the two with the naked eye. Carrying the Certificate of Authenticity (COA) and proof of purchase is strongly recommended to avoid being detained while the product is being analyzed. The legal implications for driving deserve special attention: driving after consuming CBD is discouraged, as current saliva tests cannot differentiate between CBD and THC.
When traveling within the Schengen Area with CBD products, always carry the Certificate of Analysis (COA) for the batch, the purchase invoice, and, if possible, an English translation of the COA. Some Schengen countries have different THC limits or stricter regulations regarding CBD flowers. Check the legislation of your destination country before you travel.
Side effects, drug interactions and precautions
The overall safety profile of CBD is favorable according to a clinical review published on PMC, but adverse effects exist and long-term studies are still lacking.
The ANSM lists the following adverse effects:
- Drowsiness and fatigue
- Diarrhea and digestive problems
- Nausea
- Dizziness
- Dry mouth
- Decreased appetite
- Hypotension
Do not drive after consuming CBD. Drowsiness is the most frequently reported effect, and the risk of an accident is real.
| at-risk population | Identified interaction or risk | Recommendation |
|---|---|---|
| People taking anticonvulsants | Modification of hepatic metabolism (CYP450) | Consult a doctor before use |
| People on immunosuppressants | Risk of altered plasma concentrations | Medical opinion required |
| People taking sedatives or anxiolytics | Additive effect on sedation | Avoid without medical advice |
| Pregnant or breastfeeding women | Insufficient data on fetal/neonatal safety | Not recommended |
| People taking anticoagulants | Possible metabolic interaction | Consult a doctor |
CBD affects the liver's cytochrome P450 enzymes, which can alter the plasma concentration of many medications. If you are taking any medication for an ongoing condition, consulting a doctor beforehand is not an unnecessary precaution.
Regarding product quality: according to a recent analysis, nearly 30% of the CBD oils analyzed showed concentration discrepancies or traces of contaminants compared to the declared values. This is precisely why a Certificate of Analysis (COA) for each batch, issued by an accredited independent laboratory, remains the only reliable guarantee.
Note: Epidyolex® is the only CBD-based medication authorized in France, and only for certain forms of severe epilepsy. CBD sold over the counter is not a medication and has no therapeutic claims validated by health authorities.
You have purchased a CBD food product: what should you do?
If you purchased a CBD gummy, swallowable oil or infusion before or after May 15, 2026, here are the steps to follow.
-
Keep the product and proof of purchase. Do not discard the packaging: the batch number, manufacturing date, and manufacturer's contact information are essential for any claims.
-
Contact the seller. Request a refund or return, citing regulatory non-compliance. A seller acting in good faith will readily agree.
-
Check if the product is subject to a recall. Visit rappel.conso.gouv.fr and search for the product or brand name.
-
Report an adverse effect. If you have experienced a health problem after consumption, report it to your doctor and on the ANSM reporting platform (signalement-sante.gouv.fr).
-
File a report with the DGCCRF. The SignalConso platform (signal.conso.gouv.fr) allows you to report a non-compliant product in a few minutes.
-
seller refuses a refund, you can contact the consumer mediator responsible for your sector or file a complaint with the DGCCRF (French Directorate General for Competition Policy, Consumer Affairs and Fraud Control). A class action lawsuit is possible if several consumers are affected by the same batch.
The chronology of legal decisions that have shaped the current framework
Understanding where this framework comes from helps to anticipate what might still change.
2019 — Kanavape ruling (CJEU): The Court of Justice of the European Union ruled that CBD is not a narcotic within the meaning of the Vienna Convention and that France cannot prohibit the importation of CBD legally produced in another Member State. This marked the beginning of partial liberalization.
December 29, 2022 — Council of State ruling: The Council of State partially annuls the 2021 decree, notably the restrictions on the sale of flowers in shops, reinforcing the free movement of compliant flowers. The complete timeline is available on drogues.gouv.fr.
2024–2025 — EFSA Provisional Opinion: EFSA publishes its provisional elements on a safe level of exposure to CBD and requests additional data from Novel Food applicants. No authorization is granted.
May 15, 2026 — Strict Novel Food Enforcement: France sets this date as the tipping point for the effective implementation of the ban on CBD foods without authorization. Non-compliant stocks must be withdrawn.
Official texts are available on EUR-Lex for European regulations, on Légifrance for French decrees, and on the European Commission website for Novel Food decisions.
What to do today if you are a consumer or a shop?
For consumers:
- Stop buying CBD oils to swallow, gummies, infusions or food supplements until further regulatory notice.
- Check that your current products (flowers, e-liquids, cosmetics) are accompanied by a valid COA per batch.
- Consult a doctor if you are taking chronic medication and wish to use CBD.
- If you have any doubts about a product, consult rappel.conso.gouv.fr before consumption.
For the shops:
- Audit your stock immediately: remove all food products containing CBD (gummies, oral oils, infusions, supplements).
- Update your online product listings to remove any claims of ingestion on non-food products.
- Train your staff to explain the ingestion/non-ingestion distinction to customers.
- Make your COAs accessible in store and online, by batch number.
Transparency is no longer an optional selling point. It is a legal obligation and, for shops that comply, a real competitive advantage over operators who continue to sell non-compliant products.
Business tip: Focus on categories that remain legal and have strong demand: certified hemp flowers and resins, e-liquids, cosmetics, and topicals. These are precisely the segments where quality and traceability make all the difference to discerning consumers.
The CBD market in France deserves better than vague regulations
The implementation date of May 15, 2026, had been anticipated for at least two years. Yet, some in the market continued selling CBD food products as if the Novel Food authorization were about to expire. It didn't, and consumers are paying the price as much as the unprepared retailers.
What strikes me is the disproportion between the strictness imposed on legitimate sellers and the ease with which non-compliant products continue to circulate on certain online platforms. A brick-and-mortar retailer who removes their gummies from the shelves complies with the law and loses revenue. A foreign operator delivering from a warehouse outside the EU continues without any visible oversight. This asymmetry is a genuine public policy issue, not just a minor matter of enforcement.
For shops that have been transparent from the start, offering accessible Certificates of Analysis (COAs), certified strains, and honest communication about what CBD can and cannot do, this period is uncomfortable but not fatal. The market for non-ingestible products remains open, and the demand for quality flowers, resins, and e-liquids is not waning. This is where responsible businesses stand to gain the most.
Lord Of CBD: compliant products, batch analyses available
All products come from rigorously selected organic hemp producers, with traceability from seed to finished product.
No oils to swallow, no gummies, no unauthorized dietary supplements: the selection focuses on legal categories, those where analytical quality truly makes a difference. For consumers who want to buy premium CBD with free shipping, Lord Of CBD is a direct option, without intermediaries and with a clear return policy. Contact customer service to obtain the certificate of analysis for your batch before or after ordering.
Sources
To verify, report or delve deeper, here are the primary sources to consult:
- Provisional safe level for cannabidiol (CBD) – EFSA
- Novel food – European Commission
- An Update on Safety and Side Effects of Cannabidiol: A Review – PMC
- Drugs
This article provides general information and is not a substitute for legal advice. Consult a qualified legal professional regarding your specific situation before taking any action based on this content.
Leave a comment
You must be logged in to post a comment.